TABLE 1 .

Linezolid use and linezolid MICs

Case	Date LRCoNS was isolated (mo/yr)	Linezolid MIC (µg/ml)	Hospital day LRCoNS was isolated	No. of days of prior linezolid exposure
S. epidermidis
1	1/2010	128	19	8
2	2/2011	256	7	7
3	3/2011	>256	37	9
4	6/2011	32	120	28
5	7/2011	8	1	20
6	9/2011	128	1	6
7	5/2007	16	20	6
13	11/2007	8	12	17
14	4/2008	>256	1	14
15	6/2008	>256	Outpatient	14
17	6/2008	32	84	24
18	8/2008	32	5	24
19	8/2008	32	135	7
20	10/2008	128	23	21
21	11/2008	32	97	22
22	11/2008	16	21	80
23	12/2008	>256	41	19
25	9/2009	>256	19	3
26	10/2009	64	64	31
27	9/2009	32	25	9
28	10/2009	128	9	3
S. haemolyticus
8	5/2007	64	64	42
9	4/2007	64	32	9
10	10/2007	64	1	17
11	10/2007	64	1	0
12	10/2007	128	57	30
16	7/2008	64	1	NDa
24	7/2009	64	123	23
Avg (SD)			38.5 (41.7)	16 (10)

^aND, no data.